Chia-Lin Simmons - 15 Feb 2024 Form 3 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Chia-Lin Simmons
Issuer symbol
CHRO
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
3
Filing time
15 Feb 2024, 20:31:00 UTC
Previous filing
09 Aug 2023
Next filing
05 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CHRO Stock Options 15 Feb 2024 Common Stock 15,000 $22.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 9, 2023, the Reporting Person was granted stock options to purchase 15,000 shares of common stock at an exercise price of $22.68 per share. 1,667 shares of such options became exercisable on March 31, 2023, 1,667 shares of such options became exercisable on June 30, 2023, 1,667 shares of such options became exercisable on September 30, 2023, 1,667 shares of such options became exercisable on December 31, 2023, 1,667 shares of such options will become exercisable on March 31, 2024 and the remaining 8,335 shares of such options shall become exercisable in equal installments on a quarterly basis, subject to the Reporting Person's continued service to Issuer. The final installment shall become exercisable on March 31, 2025, subject to the Reporting Person's continued service to Issuer.

Remarks:

Exhibit 24 - Power of Attorney